Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

373 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real prevalence of neural tube defects in Japan: How many of such pregnancies have been terminated?
Kondo A, Akada S, Akiyama K, Arakawa M, Ichi S, Inamoto Y, Ishida T, Ishikawa H, Itoh T, Izumi A, Kimura F, Kondo AS, Matsuoka R, Miyauchi A, Mochizuki J, Momohara Y, Morikawa S, Morioka M, Morota N, Nakabe K, Obayashi S, Oku M, Samura O, Sasahara J, Sase M, Shimamoto K, Shimamura K, Sumigama S, Tada K, Takahashi H, Tani A, Wada S, Wada-HIraike O, Watanabe T, Yamaguchi M, Yasui T, Yokomine M. Kondo A, et al. Among authors: inamoto y. Congenit Anom (Kyoto). 2019 Jul;59(4):118-124. doi: 10.1111/cga.12333. Epub 2019 Apr 3. Congenit Anom (Kyoto). 2019. PMID: 30883906
Stroke incidence and case fatality in Shiga, Japan 1989-1993.
Kita Y, Okayama A, Ueshima H, Wada M, Nozaki A, Choudhury SR, Bonita R, Inamoto Y, Kasamatsu T. Kita Y, et al. Among authors: inamoto y. Int J Epidemiol. 1999 Dec;28(6):1059-65. doi: 10.1093/ije/28.6.1059. Int J Epidemiol. 1999. PMID: 10661648
ASTCT Committee on Practice Guidelines Survey on Evaluation and Management of Relapsed/Refractory Multiple Myeloma after Failure of Chimeric Antigen Receptor T Cell Therapy.
Hashmi H, Kumar A, Kharfan-Dabaja MA, Munshi PN, Inamoto Y, DeFilipp ZM, Dholaria B, Jain T, Perales MA, Carpenter PA, Hamadani M, Dhakal B, Usmani SZ. Hashmi H, et al. Among authors: inamoto y. Transplant Cell Ther. 2024 Apr 12:S2666-6367(24)00347-6. doi: 10.1016/j.jtct.2024.04.007. Online ahead of print. Transplant Cell Ther. 2024. PMID: 38615990 Free article.
Severity of Chronic Graft-versus-Host Disease and Late Effects Following Allogeneic Hematopoietic Cell Transplantation for Adults with Hematologic Malignancy.
Lee CJ, Wang T, Chen K, Arora M, Brazauskas R, Spellman SR, Kitko C, MacMillan ML, Pidala JA, Badawy SM, Bhatt N, Bhatt VR, DeFilipp Z, Diaz MA, Farhadfar N, Gadalla S, Hashmi S, Hematti P, Hossain NM, Inamoto Y, Lekakis LJ, Sharma A, Solomon S, Lee SJ, Couriel DR. Lee CJ, et al. Among authors: inamoto y. Transplant Cell Ther. 2024 Jan;30(1):97.e1-97.e14. doi: 10.1016/j.jtct.2023.10.010. Epub 2023 Oct 14. Transplant Cell Ther. 2024. PMID: 37844687
Improved Long-Term Net Survival after Allogeneic Hematopoietic Cell Transplantation in Patients with Hematologic Malignancies over Two Decades.
Ohbiki M, Ito Y, Inamoto Y, Miyamura K, Uchida N, Fukuda T, Fujiwara H, Nishida T, Hayashi M, Tanaka M, Kawakita T, Ikegame K, Katayama Y, Ara T, Ichinohe T, Kiyoi H, Matsuo K, Atsuta Y. Ohbiki M, et al. Among authors: inamoto y. Transplant Cell Ther. 2023 Dec;29(12):768.e1-768.e10. doi: 10.1016/j.jtct.2023.09.010. Epub 2023 Sep 21. Transplant Cell Ther. 2023. PMID: 37739224
373 results